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Inflammatory Responses in the Cerebral Cortex After
Ischemia in the P7 Neonatal Rat
N. Benjelloun; S. Renolleau, MD; A. Represa, PhD; Y. Ben-Ari, PhD; C. Charriaut-Marlangue, PhD
Background and Purpose—The contribution of inflammatory response to the pathogenesis of ischemic lesions in the
neonate is still uncertain. This study described the chronological sequence of inflammatory changes that follow cerebral
ischemia with reperfusion in the neonatal P7 rat.
Methods—P7 rats underwent left middle cerebral artery electrocoagulation associated with 1-hour left common carotid
artery occlusion. The spatiotemporal pattern of cellular responses was characterized immunocytochemically with the use
of antibodies against rat endogenous immunoglobulins to visualize the area of the breakdown of the blood-brain barrier.
Infiltration of neutrophils and T lymphocytes was demonstrated by antibodies against myeloperoxidase and a pan-T cell
marker, respectively. Antibodies ED1 and OX-42 were applied to identify microglial cells and macrophages. The
response of astrocytes was shown with antibodies against glial fibrillary acidic protein. Cell survival was assessed by
Bcl-2 expression. Cell death was demonstrated by DNA fragmentation with the use of the terminal deoxynucleotidyl
transferase–mediated dUTP biotin nick end labeling (TUNEL) assay and Bax immunodetection.
Results—Endogenous immunoglobulin extravasation through the blood-brain barrier occurred at 2 hours of recirculation
and persisted until 1 month after ischemia. Neutrophil infiltration began at 24 hours and peaked at 72 to 96 hours
(3063.4 neutrophils per 0.3 mm2; P,0.0001), then disappeared at 14 days after ischemia. T cells were observed
between 24 and 96 hours of reperfusion. Resident microglia-macrophages exhibited morphological remnants and
expressed the cell death inhibitor Bcl-2 at 24 hours of recirculation. They became numerous within the next 48 hours
and peaked at 7 days after ischemia. Phenotypic changes of resident astrocytes were apparent at 24 hours, and they
proliferated between 48 hours and 7 days after ischemia. Progressively inflammatory cells showed DNA fragmentation
and the cell death activator Bax expression. Cell elimination continued until there was a complete disappearance of the
frontoparietal cortex.
Conclusions—These data demonstrate that perinatal ischemia with reperfusion triggers acute inflammatory responses with
granulocytic cell infiltration, which may be involved in accelerating the destructive processes. (Stroke.
1999;30:1916-1924.)
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Perinatal ischemic brain injury may lead to the death ofneonates and important neurological impairment mani-
fested as cerebral palsy and mental retardation in the surviv-
ing infants.1–3 This is due to the fact that the basal ganglia as
well as certain regions of neocortex are relatively vulnerable
to injury in the neonatal period.4 Perinatal asphyxia, with its
attendant bradycardia and hypotension, is an ischemic con-
dition that is followed by reperfusion on resuscitation.
Reperfusion after an ischemic episode elicits in adult
brains the appearance of deleterious blood leukocytes, poten-
tially a source of toxic free radicals and cytokines causing
inflammatory reactions and leading to a delayed death of
neurons and the expansion of cerebral damage (for reviews,
see References 5 and 6). In contrast, the physiological events
that follow reperfusion in the neonate have not been largely
examined. With the use of the classic model of Rice et al7 in
See Editorial Comment, page 1923
7-day-old rats, neuronal death was found to be associated
with an activation of both microglia and astrocytes, while
granulocytic cells were not involved.8–10 It is presently
unclear whether those effects result from the combination of
both processes (ischemia and hypoxia) or from ischemic
insult alone. To investigate the mechanisms of reperfusion
injury, we recently developed a model of stroke by transient
unilateral focal ischemia in P7 rats by permanent left middle
cerebral artery (MCA) occlusion with 1-hour occlusion of the
left common carotid artery. Ischemia with reperfusion in the
anastomoses via the carotid artery produced a well-delineated
cortical infarct at 48 hours of reperfusion11 and neuronal
death with features characteristic of apoptosis.11,12
This study was designed to investigate inflammatory re-
sponses in this model between 2 hours and 3 months of
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reperfusion. Our data strongly suggest that inflammatory cells
may be involved in promoting secondary cell death in
neonatal ischemia with reperfusion.
Materials and Methods
Animals and Neonatal Ischemia
Experiments involving animals were approved by the French Ethical
Science Committee (statement No. 04223). Experiments were per-
formed in 7-day-old Wistar rats (weight, 15 to 23 g) of both sexes,
as previously described.11 Rat pups were anesthetized with an
injection of chloral hydrate (300 mg/kg IP). After 15 minutes, rats
were placed on their back, and a median incision was made in the
neck to expose the left common carotid artery. Rats were then placed
on the right side, and an oblique skin incision was made between the
ear and the eye. After excision of the temporal muscle, the cranial
bone was removed from the frontal suture to a level below the
zygomatic arch. Then the left MCA, exposed just after its apparition
over the rhinal fissure, was coagulated at the inferior cerebral vein
level. After this procedure, a clip was placed to occlude the left
common carotid artery and was removed after 1 hour. Carotid blood
flow restoration was verified with the aid of a microscope. Both neck
and cranial skin incisions were then closed. The surgical procedure
lasted approximately 20 minutes. During surgery, body temperature
was maintained at 37°C to 38°C. Rat pups were placed in an
incubator maintained at 37°C until they woke up, and then they were
transferred to their mother for long-time survival.
Tissue Preparation
Each of the following survival times after reperfusion studied was
represented by a group of 5 animals: 6, 24, 72, and 96 hours; 7 and
14 days; and 1 and 3 months. At each point, animals were perfused
transcardially with warm heparinized saline followed by a
phosphate-buffered solution (0.1 mol/L, pH 7.4) containing 4%
paraformaldehyde. Brains were immediately removed and postfixed
for 1 hour in the same fixative solution at room temperature. Then
they were placed in a phosphate-buffered solution containing 10%
sucrose for 2 days at 4°C. The brains were frozen in isopentane at
240°C. They were then stored at 280°C until used. For control, 2
sham age-matched rats were killed and processed in the same way.
Coronal cryostat sections (10 mm thick) were collected on gelatin-
coated slides. Cresyl violet was used to identify the site of the lesion
and to evaluate degenerating cells.
Immunocytochemistry
Antisera
A mouse monoclonal antibody against glial fibrillary acidic protein
(GFAP) (1:200, Boehringer Mannheim) was used to visualize
astrocytes. Rat microglia and brain macrophages were immuno-
stained by the mouse monoclonal antibody OX-42 (1:500, Serotec)
and ED1 (1:500, Serotec). OX-42 recognizes the complement C3bi
receptor expressed by monocytes/macrophages and activated rami-
fied and ameboid microglia. ED1 antibodies label most rat macro-
phages, peripheral blood monocytes, and activated microglia.13 The
area of leakage of the blood-brain barrier (BBB) was identified by
immunodetection of rat endogenous immunoglobulins in brain pa-
renchyma (1:200, Dako). Rabbit antibodies against myeloperoxidase
(MPO) (1:200, Sigma) were used to visualize polymorphonuclear
leukocytes (PMNL). Mouse monoclonal antibodies against rat T
lymphocyte (Pan-T, 1:200, Serotec) were used to identify infiltrating
T lymphocytes. Bcl-2 antibodies were purchased from Boehringer
Mannheim and Bax (P-19) antibodies from Santa Cruz (Tebu). They
recognized p26 and p21 proteins to identify key regulators of
apoptosis in surviving and dying cells, respectively.
Immunostaining Procedure
Sections were incubated overnight at 4°C in the first antibody at the
dilution indicated above in PBS 0.1 mol/L containing 2% BSA, 0.3%
Triton X-100. The secondary (anti-rabbit or anti-mouse IgG) biotin-
ylated antibodies (1:200 to 1:400 dilution, Dako) were visualized by
the avidin-biotin peroxidase (Elite ABC kit, Vectastain Vector,
Byosis). The peroxidase activity was evidenced with the use of 0.1
mol/L phosphate buffer containing 0.025% 3,39-diaminobenzidine
(DAB) and 0.02% hydrogen peroxide. Nonspecific peroxidase ac-
tivity was abrogated by incubating the sections in 2% hydrogen
peroxide in 10% methanol at the appropriate stage. Some immuno-
Figure 1. Histopathological changes after neonatal ischemia.
Cresyl violet–stained sections (bregma 0.2 mm) show frontopari-
etal cortex of control rat (A) and rats subjected to unilateral per-
manent electrocoagulation of the MCA associated with 1-hour
common carotid occlusion followed by various recovery inter-
vals (B through F). A, General view of the cortex of a 7-day-old
rat pup showing normal cytoarchitecture. B, Note the important
cortical thickness at 72 hours of reperfusion with the formation
of a gliotic wall (curved white arrows) surrounding the infarcted
zone (I). C, Loss of the upper cortical layers and formation of a
cavity in the infarcted area (black arrow) at 7 days of reperfu-
sion. Note the arrangement of the molecular layer I of adjacent
noninfarcted cortical area (small black arrows). D, At 3-month
recovery, complete loss of the frontoparietal ischemic cortex is
shown. E, F: Details of panel B at higher magnification. E, Dying
neuron showing pyknotic nucleus (black arrow). F, Glial cell at
the periphery of the infarct showing mitotic figure (white arrow).
I through VI indicate layers of the cerebral cortex; cc, corpus
callosum; and St, striatum. Bar represents 50 mm in A through
D and 10 mm in E and F.
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stained sections were counterstained with hematoxylin for localiza-
tion of the labeled cells. In double-labeling experiments, sections
were first incubated with antibodies against GFAP, OX-42, or ED1
and revealed by the avidin-biotin alkaline phosphatase (ABC kit,
Vectastain Vector) with the Substrate Kit III (Vector Blue). They
were then incubated with anti-Bax and visualized with peroxidase
and DAB.
In Situ Labeling of Fragmented DNA
Coronal cryostat sections were processed for terminal deoxynucleo-
tidyl transferase–mediated dUTP biotin nick end labeling (TUNEL)
assay, as previously reported.14 Briefly, sections were incubated with
terminal deoxynucleotidyl transferase (0.2 U/mL; Gibco) and biotin-
16-dUTP (20 mmol/L; Boehringer Mannheim), then visualized with
streptavidin-biotin-peroxidase complex and diaminobenzidine.
Quantification of Neutrophils
Quantification of neutrophils was performed with the use of a 340
objective and a camera lucida attached to the microscope. At
different times after ischemia, in the 5 ischemic animals, intraparen-
chymal MPO-positive neutrophils were counted in a 0.3-mm2 circu-
lar area on 3 sections containing the infarct. The statistical signifi-
cance of the results was evaluated by the unmatched Student’s t test.
Results
Sections used in the figures are representative of the 5
animals analyzed in each group at each time period.
Histopathology
Figure 1 shows the cytoarchitecture and cell morphology of
the cortex from control (Figure 1A) and ischemic (Figure 1B
through 1D) rat pup brains after examination of cresyl
violet–stained sections. At 72 hours of reperfusion (Figure
1B), the infarcted area collapsed and demonstrated cells with
coarse chromatin clumping and nuclear pyknosis (black
arrow in Figure 1E). At the periphery of the infarct, a more
marked hypercellular band (white curved arrows in Figure
1B) appeared and showed several mitotic figures (white
curved arrow in Figure 1F). One week after the ischemic
insult, the infarcted area cleared progressively of neuronal
perikarya. Cortical upper layers disappeared, and a cavity was
formed (Figure 1C, black arrow). By 2 weeks of reperfusion,
the ipsilateral hemisphere appeared reduced compared with
the contralateral hemisphere (not shown). The loss of the
frontoparietal cortex was completed 3 months after recovery
(Figure 1D).
Early BBB Impairment, PMNL, and
Lymphocyte Infiltration
Endogenous immunoglobulin extravasation was only ob-
served in the ischemic ipsilateral hemisphere and appeared as
Figure 2. Status of the BBB and infiltrating
cells after ischemia/reperfusion in neonatal
rats. A, Rat immunoglobulin immunostaining
demonstrating the leakage at the BBB at 72
hours after ischemia. Note that the leakage
area is bigger than the infarcted zone (I). Stars
(,, p) indicate area enlarged in B and C,
respectively. B, Neurons within the infarct im-
munostained by anti-rat immunoglobulins. C,
Cells exhibiting glial phenotype localized at
the periphery of the infarcted area immuno-
stained by anti-rat immunoglobulins. D, Rat
immunoglobulin–immunostained cells within
the substantia nigra in the ipsilateral hemi-
sphere. E, F, PMNL with typical segmented
nuclei (MPO positive). E, Polymorphonuclear
cells in the upper layers of the infarcted cortex
at 48 hours of reperfusion. Arrow indicates
that MPO-positive cells invaded the cortical
layers from layer I to layer VI. F, Polymorpho-
nuclear cells in large number within the infarct
at 96 hours of reperfusion. G, Lymphocytes in
the hemisphere ipsilateral to the ischemic
lesion at 24 hours of reperfusion. Sections in
E and F have been counterstained by hema-
toxylin. I indicates infarct; P, periphery. Bar
represents 40 (A) and 10 (B through G) mm.
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early as 2 hours after reperfusion in the core of the infarct. At
72 hours, the area of BBB leakage was larger than the
infarcted area (Figure 2A). Altered cells within the infarct
(Figure 2B), glial cells at the periphery of the infarct (Figure
2C), and nonaffected neurons located in regions without the
BBB and occasionally in the substantia nigra (Figure 2D)
were immunostained by anti-rat immunoglobulins. Anti-rat
immunoglobulin immunostaining was still observed 1 month
after reperfusion in the ipsilateral hemisphere, but not
thereafter.
PMNL were detected in the ischemic tissue at 24 hours of
reperfusion. At this point, they were essentially observed in
arachnoid spaces and associated with intraparenchymal blood
vessels within and near the lesioned area (not shown).
Progressively, PMNL invaded the upper layers of infarcted
cortex from 48 to 96 hours of recovery (Figure 2E and 2F).
Intraparenchymal neutrophils peaked at 72 to 96 hours of
reperfusion (Figure 3). No PMNL were observed after 2
weeks of reperfusion. Infiltrating lymphocytes (pan-T immu-
noreactive cells) were transiently observed between 24 and
96 hours of recovery and were preferentially located in the
white matter of the ipsilateral hemisphere, notably the corpus
callosum (Figure 2G), the internal capsule, and often in close
vicinity to blood vessels.
Time Course of Microglia/Macrophage Responses
Activated OX-42–immunostained microglia/macrophages in
neonatal ischemic rat brain were detected at the periphery of
the infarcted region at 72 hours of reperfusion (Figure 4A).
They increased in number and progressively invaded the
injured tissue between 96 hours and 1 week of reperfusion
(Figure 4B) and expressed the survival promoter Bcl-2.15
Bcl-2–immunoreactive cells showed cell bodies and numer-
ous long, thin processes (called ramified microglia) (Figure
4C and 4D) or stout processes (called ameboid microglia)
(Figure 4E). Quiescent microglia in sham pups was not
immunostained by Bcl-2 antibodies (not shown). OX-42–im-
munostained microglia persisted around the cavity several
weeks after ischemia.
ED1 antibody identified macrophages, round cells that had
a smooth surface and lacked processes; they appeared first in
the lateral ventricle and migrated along the corpus callosum
at 24 hours of recovery (Figure 4F). A prominent increase in
their accumulation was observed between 72 hours and 1
week of reperfusion, and these cells invaded the infarcted
area (Figure 4G). Pseudopodic and ramified ED1-positive
microglia/macrophages remained present in the infarcted area
at later times of reperfusion.
Time Course of Astroglial Cell Responses
During the first month of life, control rat brains showed
GFAP-positive astrocytes predominantly in the corpus callo-
sum and the internal capsule. The molecular layer of the
cortex and perivascular spaces showed weak immunostained
GFAP-positive astrocytes (Figure 5A through 5C). The in-
farcted cortical area of ischemic rats showed increased GFAP
immunoreactivity 24 to 48 hours after reperfusion. Reactive
astrocytes formed a dense network delineating the infarcted
area (Figure 5D and 5E). Reactive GFAP-immunostained
Figure 3. Density of intraparenchymal neutrophils in the ipsilat-
eral cortex at different times of reperfusion. Student’s t test indi-
cates a significant increase of neutrophils at 48, 72, and 96
hours and 7 days of recirculation compared with that found at
24 hours (**P,0.0001). MPO-positive cells were counted in
12-mm-thick sections; n55 to 8 sampling areas from 5 rats at
each time point.
Figure 4. Microglia/macrophage activation in neonatal ische-
mia/reperfusion identified by immunocytochemistry using the
OX-42 antibody. A, Reactive microglial cells (OX-42 positive) at
the periphery of the infarct at 72 hours of reperfusion. B, Pro-
gression of OX-42 immunostaining from the periphery to the
core of the infarct at 7 days of reperfusion. C through E, Bcl-2–
immunostained cells showing morphology similar to that of
microglial cells at 72 hours of reperfusion. D, E, Higher magnifi-
cation of Bcl-2–positive cells showing a typical punctiform label-
ing. Note ramified type of activated microglial cells (white arrow
in D) and pseudopodic type of activated microglia located in the
subcortical white matter (white arrows in E). F, ED1-positive
macrophages at the periphery of the infarct at 24 hours of
reperfusion. G, Round ED1-positive cells within the infarct at 7
days of reperfusion. P indicates periphery; I, infarct; and cc,
corpus callosum. Bar represents 40 (A through C, F), 25 (D, E),
and 10 (G) mm.
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cells have a small soma and long processes directed toward
the subpial spaces and the core of the infarct (Figure 5F). One
week after the ischemic insult, strongly GFAP-immuno-
stained astrocytes were observed at the periphery and within
the infarct (Figure 5G). After the second week of recovery,
reactive astrocytes within the infarct showed features of
degradation, including a decrease in GFAP immunostaining
in fragmented processes and residual star-shaped cell ele-
ments (Figure 5H). From 14 days until 2 months after
reperfusion, astrocyte processes closely surrounded the
smooth-walled cavity (Figure 5I).
Cell Death: Did Glial Cells Undergo Apoptosis?
Cells exhibiting DNA fragmentation were shown as early as
6 hours; they increased and peaked at 24 to 96 hours.11
During the next 2 weeks, the infarct developed a smooth-
walled cavity (Figure 1), and TUNEL-positive cells were
observed around this cavity (Figure 6A). These cells, with
different morphology, exhibited the death promoter gene
Bax, expressed by dying cells,16 as demonstrated by immu-
nostaining of adjacent sections (Figure 6B). At 1 month of
recirculation, Bax-positive cells were detected at the periph-
ery of the infarct (Figure 6C), but these cells displayed a glial
morphology (Figure 6D). The staining of sections with both
Bax and GFAP or OX-42 antibodies revealed the presence of
double-labeled astrocytes (Figure 7A) and microglia (Figure
7B) at the periphery of the infarct between 14 and 30 days of
recovery.
Discussion
The present study shows that ischemia/reperfusion in imma-
ture rats induces progressive tissue destruction, leading to a
well-delineated lesion in the ipsilateral cortex at 3 months
after recovery. BBB impairment followed by gliosis and
infiltration of leukocytes provides evidence of a strong local
inflammatory response (summarized in the Table). At later
times of reperfusion, cells integrated in the inflammatory
response were eliminated through an apoptotic pathway.
The BBB was reported to contribute to the progression of
the cellular injury, as suggested in other models of cerebral
ischemia (for review, see Reference 15). The labeling of
neurons by anti-rat immunoglobulins within the ipsilateral
hemisphere may reflect a nonspecific uptake of extravasating
immunoglobulins rather than specific recognition, as previ-
ously described in other pathological processes16; that of
Figure 5. Morphological remnants of astro-
cytes in neonatal ischemia/reperfusion identi-
fied by immunohistochemistry using the GFAP
antibody. A, Distribution of GFAP-positive
astrocytes in the frontoparietal cortex from
7-day-old control rat. Note that GFAP-positive
cells are localized in subpial spaces and
around vessels. B, Astrocyte processes
directed toward subpial spaces. C, Astrocyte
processes surrounding a vessel in the cortex.
D, The infarcted area at 72 hours of reperfu-
sion. Note that reactive astrocytes delineate
the infarcted zone (small arrows). E, F, Higher
magnification of reactive astrocytes.
E, Strongly GFAP-immunoreactive astrocyte
processes directed toward subpial spaces in
the infarcted cortex. F, GFAP-positive reactive
astrocyte at the periphery of the infarct with a
small soma and long processes. G, GFAP-
positive reactive astrocytes increased at 7
days of reperfusion and showed large soma
and short processes. H, Astrocytes within the
infarct showing decreased GFAP immunore-
activity at 14 days of reperfusion. I, The astro-
cytic processes delineate the cavity at 1
month of reperfusion. I indicates infarct; P,
periphery. Bar represents 50 (A and D), 25
(B and E, G through I), and 10 (C and F) mm.
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microglial cells may be due to the overexpression of the Fc
receptor during their activation.17 BBB disruption may also
induce an entry of toxic molecules, such as albumin and
excitatory amino acids. There has been increasing recognition
that the cerebrovascular endothelium participates in immune
responses as a target for cytokine action and is a source of
arachidonic acid metabolites,18 free radicals, and nitric ox-
ide.19 Furthermore, endothelial cells participate in immune
responses by the regulation of intercellular adhesion molecule
1,20 which plays a key role in leukocyte recruitment and
subsequent brain injury.21
The first immune cells to appear in the ischemic immature
tissue are T lymphocytes and PMNL. Abundant22 and small23
T-cell infiltrates have been noted after MCA occlusion in the
adult rat brain. PMNL were observed to be accumulated in
the subarachnoid spaces and blood vessels 24 hours after
reperfusion and progressively invaded the different layers of
the infarcted cortex. Perivascular intraparenchymal neutro-
phil migration into the ischemic brain has been reported to
begin as early as 624 and 2425 hours after recirculation
following ischemia/reperfusion in adult rat. In contrast, min-
imal neutrophilic response9 and lack of neutrophil extravasa-
tion during the evolution of the infarct26 were reported
following neonatal hypoxia/ischemia. Nevertheless, neutro-
phil depletion in such a model reduced brain swelling at 42
hours of recovery by approximately 70%, which was compa-
rable to the protective effect of allopurinol.26 PMNL are
known to be integrated into the acute inflammatory response
and possess extensive cytotoxic capacities, supporting their
pathological role in destructive processes. They represent an
important biological source of oxygen-derived free radicals
and generate nitric oxide underlying oxidant-mediated tissue
injury.27,28 We recently reported that perivascular reactions
mediated by nitric oxide and peroxynitrites in T lymphocytes
and polymorphonuclear cells are important in the cascade of
events that lead to brain oxidative stress in neonatal ische-
mia.29 In addition, NG-nitro-L-arginine methyl ester, an inhib-
itor of nitric oxide synthase, reduced infarct volume in a
filament model of transient MCA occlusion in the rat pup.30
Our results demonstrated a microglial activation elicited by
ischemia in immature rats that was first detected at 3 days
after injury. The presence of ED1-positive microglia-macro-
phages in the ipsilateral periventricular area has been previ-
ously reported after hypoxia/ischemia in P7 rats.31 A rapid,
relatively widespread microglial response was also demon-
strated after hypoxia/ischemia by the use of major histocom-
patibility complex II (OX-6) and complex I (OX-18) antibod-
ies,10,32 whereas macrophage infiltration may be delayed or
absent.32 A relationship between delayed neuronal loss in
tissues neighboring sites of ischemia and cytotoxin secretion
has been suggested.33 Activated microglia may release a
variety of cytokines, including interleukin-1b and tumor
necrosis factor-a, known to activate astrocyte prolifera-
tion,34,35 leukocyte infiltration,36,37 and brain edema.38 How-
ever, their role in the progression of ischemic lesion remains
uncertain.39 The association of activated microglia with
nuclear ghosts in the infarcted area also suggests that they
contribute to the removal of cell death–associated debris
induced by ischemic injury. Activated microglia after ische-
mia may act as mediators of further injury and/or as cleansing
scavengers and repair agents.40 Microglial cells seem to
express the death inhibitor protein Bcl-2. Furthermore, the
delayed expression of the cell death promotor Bax from 2
weeks until 1 month after injury suggests their death by
apoptotic features, as demonstrated in human atherosclerotic
lesions.41 Therefore, the balance between proapoptotic (Bax
proteins) and antiapoptotic (Bcl-2) elements may also ac-
count for death or survival of glial cells, respectively.
Figure 6. Cell death in the ipsilateral cortex demonstrated by
the TUNEL assay and immunostaining with anti-Bax antibodies.
A, Apoptotic nuclei (arrowheads) in the deep layers of the ipsi-
lateral cortex at 14 days of reperfusion. B, Adjacent section to
that seen in A, immunostained with the cell death promoter Bax;
white arrows indicate Bax-positive cells, corresponding to
TUNEL-positive nuclei. C, Bax-positive cells localized at the
periphery of the infarct at 1 month of reperfusion. Enlarged
panel (D) shows a Bax-positive cell exhibiting glial morphology.
Bar represents 25 (C) and 10 mm (A, B, and D).
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Evidence of interleukin-1b–converting enzyme–like immu-
noreactivity in microglial cells was recently reported, which
suggests a potential role for caspases in ischemic damage
through mediation of an inflammatory response.42 Apoptosis,
through its several steps, thus appears to be one mechanism
by which activated microglia are gradually eliminated after
cerebral ischemia and by which steady state of microglial cell
numbers is achieved in vivo.
Reactive astrocytes are believed to reestablish a protective
barrier, the glial-limiting membrane.43 Astrocytic changes in
the present model of neonatal stroke could be directed to
newly formed glia limitans around the cortical cavity. The
temporal pattern of astrocyte responses indicates that reactive
astrocytes may assist ischemic brain repair by stabilizing the
tissue surrounding neuronal injury.44 Early morphological
remnants of resident astrocytes may reflect changes in ionic
concentrations and excitatory amino acids in the area of
neuronal depletion. It is presently unclear whether these
astrocytes migrate into injured areas or locally proliferate.
However, our previous data suggested that glial cells at the
periphery of the infarct expressed proliferating cell nuclear
antigen,12 known to be involved in protective and prolifera-
tive processes. At later times of recirculation, astrocytes
exhibited DNA fragmentation and expressed the cell death
promotor Bax, suggesting that their downregulation occurred
through apoptosis, compared with microglial cells.
In conclusion, our results show that ischemia without
hypoxia in immature animals triggers microglial cell activa-
tion, astrocytic response, and granulocytic infiltration, similar
to those seen in adult brain (for comparison, see References
45 through 48). The main discrepancy between our results
and that found after neonatal hypoxia/ischemia was neutro-
phil involvement. Our results, however, did not establish a
cause-and-effect relationship between the inflammatory
markers and the progression of histological damage. To
investigate such functional outcome, experiments with in-
flammatory mediator antagonists (free radical scavengers,
anti–adhesion molecule antibodies, cytokine antagonists)49
would be of interest.
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Editorial Comment
Benjelloun et al report in the accompanying article that an
extensive inflammatory reaction in response to focal ischemia
evolves in the neonatal rat brain. To those involved in
investigations of immune and inflammatory reactions associ-
ated with brain injury, the data come as no surprise; over the
past few years, numerous reports have pointed out in a quite
detailed manner that inflammation and possibly immune
components are markedly activated de novo in brain tissue
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injured by trauma, ischemia, toxins, and infectious agents.1–3
The report by Benjelloun et al extends the subject to neonatal
life, as also reported by Hallenbeck and Kochanek1 and others
using various trauma models. Most welcomed in the present
report are (1) long-term follow-up (months); (2) the inclusion
of T-cell lymphocytes in the study (this cellular component of
the immune system has not been frequently studied); and
(3) the association of the Bcl-2/Bax system of cell death
regulatory pathways along with the inflammatory reaction.
Taken together, the report provides high-quality data that
amplify and strengthen the fact that immune/inflammatory
cells and mediators are part of the brain response to injury.
The conclusion forwarded by the authors in the abstract and
further reiterated in the article is that inflammatory responses
may be involved in accelerating the destructive process in
perinatal ischemia. With this in mind, it is of interest to point
out that the conclusion by the authors of this article, as in all
previous reports, is in marked contrast to the reputable role of
inflammation in tissue injury as defined by medical dictio-
naries, such as the Stedman’s,4 in which inflammation is
described as “. . . a dynamic complex of cytologic and
chemical reactions that occur in the affected blood vessels
and adjacent tissues in response to an injury or abnormal
stimulation . . . including: 1) the local reactions . . . , 2) . . .
removal of the injurious material, 3) the responses that lead to
repair and healing.” Similar definitions can be found in
textbooks of inflammation5 and pathology.6 Clearly, the sense
and purpose of the inflammatory reaction to repair, recon-
struct, and heal have not been favored in the discussion
sections of articles that describe the cellular and biochemical
components of the inflammatory reactions to brain ischemia/
trauma. This discrepancy is even more perplexing in view of
several important reports that demonstrate the following:
(1) lack of therapeutic benefits of glucocorticosteroids or
NSAIDs in stroke or head injury; (2) experimental models
with genetic deletion of cytokine signaling elements (eg,
tumor necrosis factor-a receptor knockout) show no protec-
tion against ischemia or other injuries (on the contrary, a
measure of vulnerability has been noted)7; (3) activated
macrophages and T-cell lymphocytes are of therapeutic
potential in brain and spinal cord injury8; and (4) some of the
most “maligned” mediators in reference to ischemic brain
injury, interleukin-1 and tumor necrosis factor-a, serve as
inducers of tolerance to certain experimental paradigms of
brain injury.9
These comments are not to be taken as intentional “con-
trarianism” to the prevalent dogma on the role of inflamma-
tion in brain injury; rather, in my opinion, it is time to adopt
a more sophisticated understanding that immune and inflam-
matory cells and mediators serve complex processes, includ-
ing healing elements.
We should seek to identify the cells/mediators that serve in
the specific functions of the reaction, aiming for suppression
of particular cells/mediators that act in specific time frames to
augment injury while enhancing cells/mediators (which could
be similar) that mediate healing at other phases after injury.
Such views may help to define better strategies for pharma-
ceuticals that may not target suppression of the inflammatory
reaction at large, including the use of specific agents that may
support regeneration/reconstruction exemplified by many
functions of the inflammatory reaction itself.
Giora Z. Feuerstein, MD, Guest Editor
Department of Cardiovascular Sciences
DuPont Pharmaceuticals Company
Wilmington, Delaware
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